Deregulation of CRT by HOXB13 results from the downregulation of TCF4 transcription factors, although aberrant activation of CRT pathway is seen in only small fractions of prostate tumours (Voeller et al, 1998; Chesire et al, 2000). The gene discussed is TCF4; the disease is prostate neoplasm.